SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-036245
Filing Date
2014-02-05
Accepted
2014-02-05 11:08:00
Documents
4
Period of Report
2014-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d671102d8k.htm 8-K 32738
2 EX-99.1 d671102dex991.htm EX-99.1 6707
3 EX-99.2 d671102dex992.htm EX-99.2 76584
4 EX-99.3 d671102dex993.htm EX-99.3 63600
  Complete submission text file 0001193125-14-036245.txt   180831
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 14574963
SIC: 2834 Pharmaceutical Preparations